In this paper ,six new mixed metal ligand complexes are reported with Cephalexin (Ceph.H)as a primary ligand and Dimethylglyoxime (DMG) as secondary ligand with metal Chloride [MCl2 .nH2O. M=Mn(II),Co(II),Cu(II),Ni(II) and Zn(II),n=0-6] ,CrCl3.6H2O.The complexes are of (1:1:1)(Metal:Ligand: Ligand) Stoichiometry.The structures of these complexes are confirmed by using FT-IR and UV- electronic spectroscopies, magnetic moments, melting points, molar conductivity measurements and the metal % analysis revealed that the complexes analyze indicates a four coordinated as (A)=[M(HDMG) (Ceph)] .M=[Ni(II)and Zn(II).Six coordinated as (B) = K2[M(DMG)(CePh)(H2O)]. M= Mn (II),Co(II) and Cu(II) and (C)=[Cr(DMG)(Ceph)]Cl2. Interestingly, the in-vitro antimicrobial studies on(CephH)and dimethylglyoxime) ligands and mixed metal ligand complexes against{(Staphylococcus aureus ,Bacillus Subtilis ,and Enterobacter Cloacae)} by measuring the zone of inhibition in mm. Electronic spectra data and magnetic measurements indicates that the most of the complexes have octahedral geometry except the complexes Ni(II)and Zn(II) have tetrahedral geometry.
Synthesis, Spectral Studies And Antimicrobial Activity Of Mixed Ligand
Complexes Of Cephalexin And Dimethylglyoxime With Some First Row
Transition Metal Ions
cephalexin
Dimethylglyoxime
Mixed-ligand
antimicrobial activity.
Publication Date
Sat May 30 2026
Journal Name
Iraqi Journal Of Science
Leucine-rich alpha-2-glycoprotein-1 as a Potential biomarker for polycystic ovary syndrome
diabetes millets
Leucine-rich alpha-2-glycoprotein-1
Luteinizing hormone
Percentage Body Fat
Polycystic ovary syndrome
Xanthine oxidase activity
Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting women of reproductive age, characterized by anovulatory, infertility and metabolic disturbances. This study aimed to assess the diagnostic accuracy of Leucine-rich alpha-2-glycoprotein-1 (LRG1) and xanthine oxidase (XO) activity as novel biomarkers for PCOS, as well as to explore the relationship between LRG1 and XO activity across different groups. A total of 150 married women, aged 18-46 years were enrolled and divided into three groups: 50 with PCOS under treatment, 50 PCOS without treatment conditions shared by women with polycystic ovary conditions, and 50 healthy women. Serum samples were analysed to measure LRG1, xanthine oxidase (XO) activity,
... Show More
